DataSheet_1_A Holistic View of the Goto-Kakizaki Rat Immune System: Decreased Circulating Immune Markers in Non- Obese Type 2 Diabetes.pdf
Type-2 diabetes is a complex disorder that is now considered to have an immune component, with functional impairments in many immune cell types. Type-2 diabetes is often accompanied by comorbid obesity, which is associated with low grade inflammation. However,the immune status in Type-2 diabetes independent of obesity remains unclear. Goto-Kakizaki rats are a non-obese Type-2 diabetes model. The limited evidence available suggests that Goto-Kakizaki rats have a pro-inflammatory immune profile in pancreatic islets. Here we present a detailed overview of the adult Goto-Kakizaki rat immune system. Three converging lines of evidence: fewer pro-inflammatory cells, lower levels of circulating pro-inflammatory cytokines, and a clear downregulation of pro-inflammatory signalling in liver, muscle and adipose tissues indicate a limited pro-inflammatory baseline immune profile outside the pancreas. As Type-2 diabetes is frequently associated with obesity and adipocyte-released inflammatory mediators, the pro-inflammatory milieu seems not due to Type-2 diabetes per se; although this overall reduction of immune markers suggests marked immune dysfunction in Goto-Kakizaki rats.
History
References
- https://doi.org//10.2174/1573399815666191024085838
- https://doi.org//10.3389/fendo.2019.00451
- https://doi.org//10.2337/dbi20-0001
- https://doi.org//10.1111/dom.13848
- https://doi.org//10.1155/2017/4275851
- https://doi.org//10.1159/000356535
- https://doi.org//10.1038/npp.2016.123
- https://doi.org//10.1111/j.1476-5381.2012.01911.x
- https://doi.org//10.1007/978-1-62703-068-7_9
- https://doi.org//10.1016/j.lfs.2012.01.019
- https://doi.org//10.1016/j.imbio.2011.05.003
- https://doi.org//10.1016/j.bbi.2019.04.042
- https://doi.org//10.1073/pnas.0810087106
- https://doi.org//10.1530/JOE-19-0239
- https://doi.org//10.3389/fimmu.2021.674532
- https://doi.org//10.4137/GRSB.S25172
- https://doi.org//10.1038/s41467-021-21308-y
- https://doi.org//10.1371/journal.pone.0017386
- https://doi.org//10.1371/journal.pone.0198507
- https://doi.org//10.1161/01.ATV.21.6.923
- https://doi.org//10.1159/000430914
- https://doi.org//10.2174/1573395054065115
- https://doi.org//10.1172/JCI66580
- https://doi.org//10.1089/jir.2008.0027
- https://doi.org//10.1615/CritRevEukarGeneExpr.v20.i2.10
- https://doi.org//10.3748/wjg.v23.i17.3043
- https://doi.org//10.3390/ijms20030649
- https://doi.org//10.1590/S0036-46652007000100009
- https://doi.org//10.1007/s00221-003-1627-x
- https://doi.org//10.4110/in.2020.20.e6
- https://doi.org//10.2337/db05-1526
- https://doi.org//10.2337/db21-0609
- https://doi.org//10.1016/S0026-0495(97)90075-5
- https://doi.org//10.2337/diabetes.48.8.1662
- https://doi.org//10.2337/diabetes.49.2.263
- https://doi.org//10.1159/000443073
- https://doi.org//10.1016/j.trsl.2018.10.001
- https://doi.org//10.1038/nm.3887
- https://doi.org//10.1111/cei.13344
- https://doi.org//10.3389/fendo.2018.00081
- https://doi.org//10.1016/j.cyto.2019.154892
- https://doi.org//10.1080/09629350400003167
- https://doi.org//10.3389/fimmu.2021.678355
- https://doi.org//10.1016/j.metabol.2014.05.014
- https://doi.org//10.1186/s12865-020-00378-5
- https://doi.org//10.4049/jimmunol.1600061
- https://doi.org//10.1002/eji.200939412
- https://doi.org//10.1002/eji.201142240
- https://doi.org//10.1007/s00125-012-2665-3
- https://doi.org//10.3109/08830185.2014.954698
- https://doi.org//10.4049/jimmunol.165.11.6314
- https://doi.org//10.1371/journal.pone.0178000
- https://doi.org//10.1055/s-2007-979001
- https://doi.org//10.1038/srep10096
- https://doi.org//10.1089/met.2012.0045
- https://doi.org//10.4172/2168-9652.1000206
- https://doi.org//10.4236/jdm.2019.94017
- https://doi.org//10.1007/s00395-004-0440-4
- https://doi.org//10.1371/journal.pone.0252711
- https://doi.org//10.4162/nrp.2009.3.4.272
- https://doi.org//10.2337/db06-1650
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity
